v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
May 31, 2025
Income Taxes [Line Items]    
Schedule of Income/(Loss) Before Income Tax Expense

Income/(loss) before income tax expense is attributable to the following geographic locations:

 

Year ended
December 31,
2025

 

Year ended
December 31,
2024

 

Year ended
December 31,
2023

Hong Kong

 

$

(1,409,614

)

 

$

(3,944,692

)

 

$

(1,297,897

)

Singapore

 

 

111,972

 

 

 

(252,611

)

 

 

(2,956,296

)

Other jurisdictions

 

 

(78,788

)

 

 

39,566

 

 

 

(86,782

)

Loss before income tax expense

 

$

(1,376,430

)

 

 

(4,157,737

)

 

 

(4,340,975

)

 
Schedule of Income Taxes Expenses Computed at the Hong Kong Statutory Tax Rate

The reconciliation of income taxes expenses computed at the Hong Kong statutory tax rate applicable to income tax expense is as follows:

 

Year ended
December 31,
2025

     

Year ended
December 31,
2024

     

Year ended
December 31,
2023

   

Net loss before tax

 

$

(1,376,430

)

 

100

%

 

$

(4,157,737

)

 

100

%

 

$

(4,340,975

)

 

100

%

Hongkong statutory income tax rate

 

 

16.5

%

   

 

 

 

16.5

%

   

 

 

 

16.5

%

   

 

Provision for income tax benefit at Hong Kong statutory income tax rate (16.5%)

 

 

(227,110

)

 

16.5

%

 

 

(686,027

)

 

16.5

%

 

 

(716,261

)

 

16.5

%

Domestic tax effects

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

   

 

Non-taxable interest income

 

 

(13,907

)

 

1.0

%

 

 

(5,477

)

 

0.1

%

 

 

(1,071,774

)

 

24.7

%

Non-deductible expenses

 

 

 

 

0.0

%

 

 

195

 

 

0.0

%

 

 

98,704

 

 

(2.3

)%

Change in valuation allowance

 

 

223,918

 

 

(16.3

)%

 

 

702,123

 

 

(16.9

)%

 

 

1,705,603

 

 

(39.3

)%

Foreign tax effects

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

   

 

Cayman

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

   

 

– Statutory tax rate difference between Cayman and Hong Kong

 

 

16,128

 

 

(1.2

)%

 

 

(9,191

)

 

0.2

%

 

 

(5,078

)

 

0.1

%

Other foreign jurisdictions

 

 

917

 

 

0.0

%

 

 

(1,623

)

 

0.1

%

 

 

(11,185

)

 

0.3

%

Effective income tax expense

 

$

 

 

 

 

$

 

 

 

 

$

 

 

 

 
Schedule of Income Taxes Paid

Income taxes paid by jurisdiction is as follows:

 

Year ended
December 31,
2025

 

Year ended
December 31,
2024

 

Year ended
December 31,
2023

Hong Kong

 

$

 

$

 

Singapore

 

 

 

 

 

Other jurisdictions

 

 

 

 

 

Total income taxes paid

 

$

 

 

 

 
Schedule of Deferred Tax Assets and Liabilities The following represents the tax effect of each major type of temporary difference.
 

December 31,
2025

 

December 31,
2024

Deferred tax asset:

 

 

 

 

 

 

 

 

Net operating losses carryforwards

 

$

15,365,786

 

 

$

15,107,318

 

Depreciation and amortization

 

 

86,843

 

 

 

128,896

 

Impairment loss on assets

 

 

537,830

 

 

 

537,830

 

Total Deferred tax asset

 

 

15,990,459

 

 

 

15,774,044

 

Valuation allowance

 

 

(15,990,459

)

 

 

(15,774,044

)

Deferred tax asset, net of valuation allowance

 

$

 

 

$

 

 
Schedule of Changes in Valuation Allowance

Changes in valuation allowance are as follows:

 

December 31,
2025

 

December 31,
2024

 

December 31,
2023

Balance as of January 1

 

$

15,774,044

 

 

$

17,407,156

 

 

15,705,088

 

Additions

 

 

223,918

 

 

 

702,123

 

 

1,705,603

 

Disposal

 

 

(7,503

)

 

 

(2,335,235

)

 

(3,535

)

Balance as of December 31

 

$

15,990,459

 

 

$

15,774,044

 

 

17,407,156

 

 
DiamiR Biosciences Corp. [Member]    
Income Taxes [Line Items]    
Schedule of Income Taxes Expenses Computed at the Hong Kong Statutory Tax Rate  

For the years ended May 31, 2025 and 2024, a reconciliation of the Company’s effective tax rate to the statutory U.S. Federal rate is as follows:

 

2025

 

2024

Income taxes at Federal statutory rate

 

21.0

%

 

21.0

%

Discounts and interest on notes

 

(2.4

)%

 

(2.1

)%

Financing costs

 

(4.3

)%

 

%

State taxes

 

%

 

(4.2

)%

Other

 

(2.3

)%

 

(1.2

)%

Change in valuation allowance

 

(14.3

)%

 

(36.3

)%

Income tax provision

 

(2.3

)%

 

(22.9

)%

Schedule of Deferred Tax Assets and Liabilities  

The Company’s deferred tax assets and liabilities consist of the following at May 31, 2025 and 2024:

 

May 31,
2025

 

May 31,
2024

Deferred tax assets:

 

 

 

 

 

 

 

 

Tax benefit of net operating loss carry-forward (NOL)

 

$

351,453

 

 

$

247,637

 

FIN48 reduction in NOL

 

 

(269,420

)

 

 

(219,793

)

Stock compensation

 

 

351,136

 

 

 

346,030

 

Research and development expenses

 

 

422,170

 

 

 

372,544

 

Other

 

 

1,152

 

 

 

2,432

 

Total deferred tax assets:

 

 

856,490

 

 

 

748,850

 

Deferred tax liabilities

 

 

(8,152

)

 

 

(4,583

)

Net deferred tax assets:

 

 

848,338

 

 

 

744,267

 

Valuation allowance for deferred tax assets

 

 

(848,338

)

 

 

(744,267

)

Deferred tax assets, net of valuation allowance

 

$

 

 

$

 

Schedule of Provision For Income Taxes  

For the years ended May 31, 2025 and 2024, the provision for income taxes consisted of the following:

 

2025

 

2024

Current:

 

 

   

 

 

Federal

 

$

16,483

 

$

112,947

State

 

 

1,456

 

 

1,456

Total current

 

 

17,939

 

 

114,403

Deferred:

 

 

   

 

 

Federal

 

 

 

 

State

 

 

 

 

Total deferred

 

 

 

 

Total

 

$

17,939

 

$

114,403

Schedule of Unrecognized Tax Benefits   The Company recognizes a tax benefit from an uncertain tax position when it is more-likely-than-not that it will be sustained upon examination by tax authorities.

Unrecognized tax benefits, May 31, 2023

 

$

217,239

Gross increases – tax positions in current period

 

 

155,305

Unrecognized tax benefits, May 31, 2024

 

 

372,544

Gross increases – tax positions in current period

 

 

49,626

Unrecognized tax benefits, May 31, 2025

 

$

422,170